Search by Drug Name or NDC
NDC 69238-2030-03 Clindamycin Phosphate 10 mg/g Details
Clindamycin Phosphate 10 mg/g
Clindamycin Phosphate is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is CLINDAMYCIN PHOSPHATE.
Product Information
| NDC | 69238-2030 |
|---|---|
| Product ID | 69238-2030_577561cd-5f28-4b41-9037-0bbc3b6a20df |
| Associated GPIs | |
| GCN Sequence Number | 007726 |
| GCN Sequence Number Description | clindamycin phosphate GEL (GRAM) 1 % TOPICAL |
| HIC3 | Q5W |
| HIC3 Description | TOPICAL ANTIBIOTICS |
| GCN | 45410 |
| HICL Sequence Number | 004045 |
| HICL Sequence Number Description | CLINDAMYCIN PHOSPHATE |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/g |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215219 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69238-2030-03 (69238203003)
| NDC Package Code | 69238-2030-3 |
|---|---|
| Billing NDC | 69238203003 |
| Package | 1 TUBE in 1 CARTON (69238-2030-3) / 30 g in 1 TUBE |
| Marketing Start Date | 2022-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.33442 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | CLINDAMYCIN PH 1% GEL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis